C Bonnal1, G Birgand2, I Lolom2, S Diamantis2, C Dumortier2, F L'Heriteau3, L Armand-Lefevre4, J C Lucet2. 1. Unité d'hygiène et de lutte contre les infections nosocomiales, hôpital Bichat-Claude-Bernard, Paris, France. Electronic address: christine.bonnal@brt.aphp.fr. 2. Unité d'hygiène et de lutte contre les infections nosocomiales, hôpital Bichat-Claude-Bernard, Paris, France. 3. CCLIN Paris Nord, Paris, France. 4. Laboratoire de bactériologie, hôpital Bichat-Claude-Bernard, Paris, France.
Abstract
PURPOSE: Surveillance of preventable healthcare associated infections and feedback of the results to clinicians is central in the efforts to improve performance. We assessed Staphylococcus aureus healthcare associated bloodstream infection (HA-BSI) as an indicator of healthcare quality. PATIENTS AND METHOD: Between 2002 and 2012, we carried out a ten-year prospective bedside surveillance of S. aureus healthcare associated bacteraemia in a 940-bed university hospital using standard definitions. RESULTS: Overall, 2784 HA-BSI were identified during the study period, among which 573 (18%) were due to S. aureus. Among these 573 S. aureus bacteraemias, 189 originated from intravascular catheters (32.8%) of which 84% (158/189) in patients outside intensive care units. The proportion of catheter related HA-BSI due to S. aureus was 56% (61/109) in PVC-related HA-BSI and 34% (103/301) in CVC-related HA-BSI. A sharp decrease of PVC-related HA-BSI from 20 to 7 per year was obtained during the same period. CONCLUSION: In our experience, S. aureus HA-BSI is a simple and useful indicator of catheter associated infections, and therefore of healthcare quality, especially in units not covered by other type of surveillance.
PURPOSE: Surveillance of preventable healthcare associated infections and feedback of the results to clinicians is central in the efforts to improve performance. We assessed Staphylococcus aureus healthcare associated bloodstream infection (HA-BSI) as an indicator of healthcare quality. PATIENTS AND METHOD: Between 2002 and 2012, we carried out a ten-year prospective bedside surveillance of S. aureus healthcare associated bacteraemia in a 940-bed university hospital using standard definitions. RESULTS: Overall, 2784 HA-BSI were identified during the study period, among which 573 (18%) were due to S. aureus. Among these 573 S. aureus bacteraemias, 189 originated from intravascular catheters (32.8%) of which 84% (158/189) in patients outside intensive care units. The proportion of catheter related HA-BSI due to S. aureus was 56% (61/109) in PVC-related HA-BSI and 34% (103/301) in CVC-related HA-BSI. A sharp decrease of PVC-related HA-BSI from 20 to 7 per year was obtained during the same period. CONCLUSION: In our experience, S. aureus HA-BSI is a simple and useful indicator of catheter associated infections, and therefore of healthcare quality, especially in units not covered by other type of surveillance.
Authors: Myriam K S Ballo; Sami Rtimi; César Pulgarin; Nancy Hopf; Aurélie Berthet; John Kiwi; Philippe Moreillon; José M Entenza; Alain Bizzini Journal: Antimicrob Agents Chemother Date: 2016-08-22 Impact factor: 5.191
Authors: Weronika M Ilczyszyn; Artur J Sabat; Viktoria Akkerboom; Anna Szkarlat; Joanna Klepacka; Iwona Sowa-Sierant; Barbara Wasik; Maja Kosecka-Strojek; Aneta Buda; Jacek Miedzobrodzki; Alexander W Friedrich Journal: PLoS One Date: 2016-03-18 Impact factor: 3.240